» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Article
VOL. 46 | NO. 24 | Friday, June 17, 2022

Vanderbilt names Berkeley structural biologist as new dean

Print | Front Page | Email this story

NASHVILLE (AP) — Vanderbilt University's School of Medicine Basic Sciences has tapped one of the world's leading structural biologists as its new dean, the school announced on Tuesday.

John Kuriyan currently serves as distinguished professor of molecular and cell biology and professor of chemistry at the University of California, Berkeley. His research focuses on molecular switches in cells, which has revealed insights into the workings of some cancer drugs. Kuriyan is a co-founder of Nurix Therapeutics, a publicly traded biotech company that is developing therapies for late-stage cancers, according to a news release from Vanderbilt.

"John Kuriyan is recognized around the world for the quality and impact of his research," said current Dean Lawrence Marnett, who will return to the faculty after a sabbatical. "He will be a beacon for attracting the very best biomedical scientists to campus."

Kuriyan earned a doctorate in physical chemistry at the Massachusetts Institute of Technology in 1986. He completed a postdoctoral fellowship at Harvard University on the dynamics of proteins. He will begin his new role at Vanderbilt on Jan. 1.

C. Cybele Raver, provost and vice chancellor for academic affairs, said Kuriyan's appointment will "catapult our research reputation forward."

Follow us on Facebook, Twitter & RSS:
Sign-Up For Our FREE email edition
Get the news first with our free weekly email
Name
Email  
TNLedger.com Knoxville Editon
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 0 0 0
MORTGAGES 0 0 0
FORECLOSURE NOTICES 0 0 0
BUILDING PERMITS 0 0 0
BANKRUPTCIES 0 0 0
BUSINESS LICENSES 0 0 0
UTILITY CONNECTIONS 0 0 0
MARRIAGE LICENSES 0 0 0